Cardiopulmonary Exercise Testing-Guided Exercise Therapy in Hypertensive Patients: A Single Center Study

Qin Lu1, Jingjing Lu1, Che Li1

  • 1Department of Cardiology The Second Affiliated Hospital of Jiaxing University, Jiaxing, Zhejiang, China.

PubMed

Insights

Cardiac rehabilitation guided by cardiopulmonary exercise testing (CPET) significantly improves blood pressure, cardiorespiratory function, and lipid metabolism in hypertensive patients. This approach offers a safe and effective enhancement to standard drug treatment.

Area of Science:

  • Cardiology
  • Exercise Physiology
  • Hypertension Management

Background:

  • Hypertension management often involves pharmacotherapy and lifestyle modifications.
  • Cardiopulmonary exercise testing (CPET) can guide personalized exercise interventions.
  • The impact of CPET-guided cardiac rehabilitation on comprehensive cardiovascular markers in hypertension requires further elucidation.

Purpose of the Study:

  • To evaluate the efficacy of CPET-guided cardiac rehabilitation versus conventional rehabilitation in Grade 1 hypertensive patients.
  • To assess the effects on cardiorespiratory function, blood pressure, blood pressure variability, and lipid metabolism.

Main Methods:

  • A randomized trial involving 67 patients with Grade 1 hypertension on antihypertensive drugs.
  • Participants were allocated to either conventional cardiac rehabilitation or CPET-guided rehabilitation for 12 weeks.
  • Key parameters including blood pressure, cardiorespiratory indicators, lipid profile, and BMI were measured pre- and post-intervention.

Main Results:

  • The CPET group demonstrated significantly lower blood pressure and improved cardiac indicators compared to the conventional group.
  • Greater improvements in cardiorespiratory endurance indicators were observed in the CPET group.
  • Significant reductions in LDL-C, TC, TG, and BMI were noted in the CPET group post-intervention.

Conclusions:

  • CPET-guided cardiac rehabilitation is an effective and safe adjunct to pharmacotherapy for managing Grade 1 hypertension.
  • This intervention improves blood pressure control, cardiorespiratory function, lipid profiles, and exercise endurance.
  • The findings support the clinical value and promotion of CPET-guided cardiac rehabilitation in hypertensive patients.

Related Concept Videos

Exercise Stress Test01:26

Exercise Stress Test

Introduction
Exercise stress testing, commonly known as a treadmill test, is a noninvasive procedure used to evaluate cardiovascular function and diagnose heart conditions.
Definition
An exercise stress test measures the heart's response to exertion using a treadmill or stationary bicycle. Chest electrodes record the heart's electrical activity through an ECG, and blood pressure is monitored regularly.
Purposes
123
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure01:16

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure

Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
95
Exercise and Cardiac Output01:17

Exercise and Cardiac Output

Regular physical activity is essential for maintaining cardiovascular health, with aerobic exercises being particularly effective. According to the American Heart Association, 150 minutes of moderate to intense aerobic exercise per week is recommended for a healthy heart. Aerobic activities may include brisk walking, running, bicycling, cross-country skiing, and swimming, ideally performed three to five times per week.
Sustained exercise increases the muscles' oxygen demand, which can be...
688
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers01:26

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
89
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists01:18

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
82
Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
637